Quality of Life in Chronic Venous Disease: Bridging the Gap Between Patients and Physicians
Clinical Drug Investigation · 2023-06 · 43 (S1) · 3-8
DOI: 10.1007/s40261-023-01264-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Drug Investigation, online erschienen am 10.05.2023. Verfasst von Fabricio Santiago. Beteiligte Einrichtung: Department of Surgery, Federal University of Goiás, Goiás, 74180-040, Brazil. fsan09@hotmail.com. Hauptthemen laut MEDLINE: Venous Insufficiency, Physicians. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Servier.
Abstract (Originalsprache)
Chronic venous disease (CVD) has a negative impact on patients' quality of life (QoL). This was demonstrated in the recent Patient Journey on CVD study, which examined QoL in patients with early- and advanced-stage CVD (Clinical, Etiological, Anatomical and Pathophysiological classification C0 to C4), and the gaps between the way in which physicians and patients viewed the impact of CVD on QoL. The study was conducted in five countries (Brazil, China, Czech Republic, Italy and Russia) and included 100 patients with CVD and 60 CVD specialists. Patients completed the 14-item Chronic Venous Insufficiency Questionnaire (CIVIQ-14) to assess their QoL, and all patients and physicians were questioned during a 60-minute qualitative structured interview, focusing on four key dimensions-physical symptoms, aesthetics/appearance, emotional impact and impact on relationships. The study found that physicians tended to focus more on physical symptoms than on other impacts of CVD and rarely measured QoL in clinical practice. Patients were significantly less satisfied with the management of their QoL than physicians perceived them to be. About 25% of patients with CVD reported disturbed sleep, but physicians did not routinely ask them how CVD affected their sleep. These data reinforce the importance of physicians obtaining information about the impact of CVD on all aspects of the patient's life, including sleep and QoL. Evidence from randomised controlled trials and real-world studies demonstrates that some veno-active drugs, particularly micronised purified flavonoid fraction, can positively impact QoL in patients with CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Federal University of Goiás, Goiás, 74180-040, Brazil. fsan09@hotmail.com.
Förderung
- Servier
Zitieren
APA
Santiago, F. (2023). Quality of Life in Chronic Venous Disease: Bridging the Gap Between Patients and Physicians. Clinical Drug Investigation, 43(S1), 3-8. https://doi.org/10.1007/s40261-023-01264-9
Vancouver
Santiago F. Quality of Life in Chronic Venous Disease: Bridging the Gap Between Patients and Physicians. Clinical Drug Investigation. 2023;43(S1):3-8. doi:10.1007/s40261-023-01264-9
BibTeX
@article{Santiago2023,
author = {Santiago, Fabricio},
title = {Quality of Life in Chronic Venous Disease: Bridging the Gap Between Patients and Physicians},
journal = {Clinical Drug Investigation},
year = {2023},
volume = {43},
number = {S1},
pages = {3--8},
doi = {10.1007/s40261-023-01264-9}
}
EUVIMED